重症监护与中间监护病房中慢性阻塞性肺疾病急性加重期行支气管镜检查与死亡率增加的相关性:2014年和2015年法国国家医疗信息化系统数据库(PMSI)分析
该研究基于法国2014年和2015年PMSI数据库,回顾性分析ICU中因COPD急性加重住院的14,491例次住院,其中2586例次接受了支气管镜检查。支气管镜组的死亡率显著更高(31.32% vs 19.8%)。倾向评分匹配后,干预组死亡率超额(OR=1.749 [1.516-2.017]),且住院时间显著延长。与死亡风险增加相关的主要诊断为肺栓塞(OR=3.251 [1.126-9.384])、细菌性肺炎(OR=1.906 [1.173-3.098])和急性呼吸衰竭(OR=1.840 [1.486-2.278])。作者认为死亡率增加可能与患者选择偏倚有关,即该操作被保留用于病情恶化者。
要点
- 在ICU因COPD急性加重住院的患者中,行支气管镜检查与住院死亡率升高相关(31.32% vs 19.8%)。
- 倾向评分匹配后,支气管镜组死亡率仍显著升高(OR=1.749 [1.516-2.017]),且住院时间显著延长。
- 与死亡风险增加相关的主要诊断为肺栓塞(OR=3.251 [1.126-9.384])、细菌性肺炎(OR=1.906 [1.173-3.098])和急性呼吸衰竭(OR=1.840 [1.486-2.278])。
- 作者认为死亡率增加可能源于患者选择偏倚,即支气管镜被保留用于病情恶化者。
适用人群与场景
- 2014年和2015年法国PMSI数据库中因COPD急性加重入住ICU的住院患者。
研究设计与关键结果
- 回顾性分析法国PMSI数据库2014年和2015年因COPD急性加重入住ICU的住院记录,共识别14,491例次住院,其中2586例次接受支气管镜检查。
- 支气管镜组死亡率为31.32%,非支气管镜组为19.8%,差异显著。
- 采用倾向评分匹配(匹配因素包括年龄、性别、SAPS 2、入院类型和支气管肿瘤)后,干预组死亡率超额(OR=1.749 [1.516-2.017]),且住院时间显著延长。
- 与死亡风险增加相关的主要诊断为肺栓塞(OR=3.251 [1.126-9.384])、细菌性肺炎(OR=1.906 [1.173-3.098])和急性呼吸衰竭(OR=1.840 [1.486-2.278])。
证据类型、等级与局限
- 证据类型:基于法国PMSI数据库的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在ICU因COPD急性加重住院期间行支气管镜检查与死亡率增加相关,这种死亡率增加似乎与患者选择偏倚有关,即该操作被保留用于病情恶化的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The course of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations, most often of infectious origin, responsible for many intensive care unit (ICU) and intermediate care unit (IMCU) admissions. Our objective was to study in-hospital mortality during severe COPD exacerbations in ICU and IMCU based on the performance of bronchoscopy.
METHODS: A retrospective analysis was carried out on stays in ICUs for COPD exacerbation from the French Programme for the Medicalisation of Information Systems databases for the years 2014 and 2015. Propensity score matching of stays made it possible to constitute two comparable groups on the factors of excess mortality described in the literature (age, sex, SAPS 2, type of admission and bronchial tumour).
RESULTS: We identified 14,491 stays for COPD exacerbation in ICUs, 2586 of which received a bronchoscopy. Mortality was significantly higher in the fibroscopy group (31.32% versus 19.8%). After propensity score matching, we found an excess of mortality in the intervention group (OR = 1.749 [1.516-2.017]) associated with a significantly longer length of stay. The main diagnoses associated with an increased risk of death were pulmonary embolism (OR = 3.251 [1.126-9.384]), bacterial pneumonia (OR = 1.906 [1.173-3.098]) and acute respiratory failure (OR = 1.840 [1.486-2.278]).
CONCLUSIONS: Performing bronchoscopy during ICU hospitalisations for severe COPD exacerbations was associated with increased mortality. This increased mortality appears to be related to a bias in patient selection with a procedure reserved for patients with the adverse course.
参考来源
- Amalric M, Ahmed E, Jung B, et al. Association between increased mortality and bronchial fibroscopy in intensive care units and intermediate care units during COPD exacerbations: an analysis of the 2014 and 2015 National French Medical-based Information System Databases (PMSI). J Intensive Care. 2021. PMID: 34130749. doi:10.1186/s40560-021-00560-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。